These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 32423512)

  • 1. Efficacy and safety of dasotraline in adults with binge-eating disorder: a randomized, placebo-controlled, fixed-dose clinical trial.
    Grilo CM; McElroy SL; Hudson JI; Tsai J; Navia B; Goldman R; Deng L; Kent J; Loebel A
    CNS Spectr; 2021 Oct; 26(5):481-490. PubMed ID: 32423512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and Safety of Dasotraline in Adults With Binge-Eating Disorder: A Randomized, Placebo-Controlled, Flexible-Dose Clinical Trial.
    McElroy SL; Hudson JI; Grilo CM; Guerdjikova AI; Deng L; Koblan KS; Goldman R; Navia B; Hopkins S; Loebel A
    J Clin Psychiatry; 2020 Sep; 81(5):. PubMed ID: 32926604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dasotraline in Children with Attention-Deficit/Hyperactivity Disorder: A Six-Week, Placebo-Controlled, Fixed-Dose Trial.
    Findling RL; Adler LA; Spencer TJ; Goldman R; Hopkins SC; Koblan KS; Kent J; Hsu J; Loebel A
    J Child Adolesc Psychopharmacol; 2019 Mar; 29(2):80-89. PubMed ID: 30694697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dasotraline in adults with attention deficit hyperactivity disorder: a placebo-controlled, fixed-dose trial.
    Adler LA; Goldman R; Hopkins SC; Koblan KS; Kent J; Hsu J; Loebel A
    Int Clin Psychopharmacol; 2021 May; 36(3):117-125. PubMed ID: 33724251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dasotraline for the Treatment of Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Trial in Adults.
    Koblan KS; Hopkins SC; Sarma K; Jin F; Goldman R; Kollins SH; Loebel A
    Neuropsychopharmacology; 2015 Nov; 40(12):2745-52. PubMed ID: 25948101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationships between clinical scales and binge eating days in adults with moderate to severe binge eating disorder in two Phase III studies.
    Citrome L; Kando JC; Bliss C
    Neuropsychiatr Dis Treat; 2018; 14():537-546. PubMed ID: 29497297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and Safety of Dasotraline in Children With ADHD: A Laboratory Classroom Study.
    Wigal SB; Hopkins SC; Koblan KS; Childress A; Kent JM; Tsai J; Hsu J; Loebel A; Goldman R
    J Atten Disord; 2020 Jan; 24(2):192-204. PubMed ID: 31375051
    [No Abstract]   [Full Text] [Related]  

  • 8. Citalopram in the treatment of binge-eating disorder: a placebo-controlled trial.
    McElroy SL; Hudson JI; Malhotra S; Welge JA; Nelson EB; Keck PE
    J Clin Psychiatry; 2003 Jul; 64(7):807-13. PubMed ID: 12934982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy, safety, and tolerability of nivasorexant in adults with binge-eating disorder: A randomized, Phase II proof of concept trial.
    McElroy SL; Coloma PM; Berger B; Guerdjikova AI; Joyce JM; Liebowitz MR; Pain S; Rabasa C
    Int J Eat Disord; 2023 Nov; 56(11):2120-2130. PubMed ID: 37584285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zonisamide in the treatment of binge-eating disorder: an open-label, prospective trial.
    McElroy SL; Kotwal R; Hudson JI; Nelson EB; Keck PE
    J Clin Psychiatry; 2004 Jan; 65(1):50-6. PubMed ID: 14744168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Randomized, Placebo-Controlled Laboratory Classroom Study of the Efficacy and Safety of Dasotraline in Children With ADHD.
    Wigal S; Tsai J; Bates JA; Sarma K; Tortorich D; Zhu H; Goldman R
    J Atten Disord; 2022 Aug; 26(10):1357-1368. PubMed ID: 35048745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized, Double-Blind, Placebo-Controlled Acute Comparator Trials of Lisdexamfetamine and Extended-Release Methylphenidate in Adolescents With Attention-Deficit/Hyperactivity Disorder.
    Newcorn JH; Nagy P; Childress AC; Frick G; Yan B; Pliszka S
    CNS Drugs; 2017 Nov; 31(11):999-1014. PubMed ID: 28980198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zonisamide in the treatment of binge eating disorder with obesity: a randomized controlled trial.
    McElroy SL; Kotwal R; Guerdjikova AI; Welge JA; Nelson EB; Lake KA; D'Alessio DA; Keck PE; Hudson JI
    J Clin Psychiatry; 2006 Dec; 67(12):1897-906. PubMed ID: 17194267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of human abuse potential of dasotraline compared to methylphenidate and placebo in recreational stimulant users.
    Koblan KS; Hopkins SC; Sarma K; Gallina N; Jin F; Levy-Cooperman N; Schoedel KA; Loebel A
    Drug Alcohol Depend; 2016 Feb; 159():26-34. PubMed ID: 26794682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time course of the effects of lisdexamfetamine dimesylate in two phase 3, randomized, double-blind, placebo-controlled trials in adults with binge-eating disorder.
    McElroy SL; Hudson JI; Gasior M; Herman BK; Radewonuk J; Wilfley D; Busner J
    Int J Eat Disord; 2017 Aug; 50(8):884-892. PubMed ID: 28481434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and Safety of SHP465 Mixed Amphetamine Salts in the Treatment of Attention-Deficit/Hyperactivity Disorder in Adults: Results of a Randomized, Double-Blind, Placebo-Controlled, Forced-Dose Clinical Study.
    Weisler RH; Greenbaum M; Arnold V; Yu M; Yan B; Jaffee M; Robertson B
    CNS Drugs; 2017 Aug; 31(8):685-697. PubMed ID: 28712074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topiramate in the treatment of binge eating disorder associated with obesity: a randomized, placebo-controlled trial.
    McElroy SL; Arnold LM; Shapira NA; Keck PE; Rosenthal NR; Karim MR; Kamin M; Hudson JI
    Am J Psychiatry; 2003 Feb; 160(2):255-61. PubMed ID: 12562571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of lisdexamfetamine for treatment of adults with moderate to severe binge-eating disorder: a randomized clinical trial.
    McElroy SL; Hudson JI; Mitchell JE; Wilfley D; Ferreira-Cornwell MC; Gao J; Wang J; Whitaker T; Jonas J; Gasior M
    JAMA Psychiatry; 2015 Mar; 72(3):235-46. PubMed ID: 25587645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, double-blind, placebo-controlled study of sibutramine in the treatment of binge-eating disorder.
    Appolinario JC; Bacaltchuk J; Sichieri R; Claudino AM; Godoy-Matos A; Morgan C; Zanella MT; Coutinho W
    Arch Gen Psychiatry; 2003 Nov; 60(11):1109-16. PubMed ID: 14609886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of Lisdexamfetamine in Adults With Moderate to Severe Binge-Eating Disorder: A Randomized Clinical Trial.
    Hudson JI; McElroy SL; Ferreira-Cornwell MC; Radewonuk J; Gasior M
    JAMA Psychiatry; 2017 Sep; 74(9):903-910. PubMed ID: 28700805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.